Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$1.46 - $3.97 $1,953 - $5,311
1,338 Added 33.98%
5,276 $19,000
Q4 2023

Feb 14, 2024

SELL
$0.96 - $1.53 $4,665 - $7,435
-4,860 Reduced 55.24%
3,938 $5,000
Q3 2023

Nov 14, 2023

BUY
$1.26 - $2.1 $2,320 - $3,868
1,842 Added 26.48%
8,798 $11,000
Q1 2023

May 15, 2023

SELL
$1.6 - $2.48 $910 - $1,411
-569 Reduced 7.56%
6,956 $11,000
Q4 2022

Jun 14, 2023

BUY
$1.68 - $2.5 $955 - $1,422
569 Added 8.18%
7,525 $14.4 Million
Q3 2022

Jun 14, 2023

BUY
$0.29 - $4.04 $165 - $2,298
569 Added 8.18%
7,525 $16.9 Million
Q2 2022

Jun 20, 2023

BUY
$3.24 - $5.85 $1,843 - $3,328
569 Added 8.18%
7,525 $24,000
Q2 2022

Mar 30, 2023

SELL
$3.24 - $5.85 $11,255 - $20,322
-3,474 Reduced 31.58%
7,525 $24,000
Q2 2022

Aug 11, 2022

SELL
$3.24 - $5.85 $11,255 - $20,322
-3,474 Reduced 31.58%
7,525 $24,000
Q1 2022

Jun 20, 2023

BUY
$4.6 - $8.83 $18,597 - $35,699
4,043 Added 58.12%
10,999 $57,000
Q1 2022

Mar 30, 2023

SELL
$4.6 - $8.83 $146,017 - $280,290
-31,743 Reduced 74.27%
10,999 $57,000
Q1 2022

May 12, 2022

SELL
$4.6 - $8.83 $146,017 - $280,290
-31,743 Reduced 74.27%
10,999 $58,000
Q4 2021

Jun 21, 2023

BUY
$7.75 - $10.05 $277,341 - $359,649
35,786 Added 514.46%
42,742 $363,000
Q4 2021

Mar 30, 2023

BUY
$7.75 - $10.05 $181,427 - $235,270
23,410 Added 121.09%
42,742 $363,000
Q4 2021

Feb 15, 2022

BUY
$7.75 - $10.05 $181,427 - $235,270
23,410 Added 121.09%
42,742 $363,000
Q3 2021

Jun 21, 2023

BUY
$7.78 - $10.0 $96,285 - $123,760
12,376 Added 177.92%
19,332 $192,000
Q3 2021

Mar 30, 2023

BUY
$7.78 - $10.0 $49,177 - $63,210
6,321 Added 48.58%
19,332 $192,000
Q3 2021

Nov 15, 2021

BUY
$7.78 - $10.0 $49,177 - $63,210
6,321 Added 48.58%
19,332 $192,000
Q2 2021

Jun 21, 2023

BUY
$9.22 - $14.48 $55,827 - $87,676
6,055 Added 87.05%
13,011 $121,000
Q2 2021

Mar 30, 2023

BUY
$9.22 - $14.48 $50,580 - $79,437
5,486 Added 72.9%
13,011 $121,000
Q2 2021

Aug 16, 2021

BUY
$9.22 - $14.48 $119,961 - $188,399
13,011 New
13,011 $121,000

Others Institutions Holding NUVB

About Nuvation Bio Inc.


  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $480M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.